Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The recently launched venture firm has secured capital commitments to its debut fund from investors including Axa and MACSF.

Satt Paris-Saclay’s portfolio company Altaroad has raised $11.7m in funding.

UK-based biopharmaceutical company raises $75m in IPO

Q&A with Cristina Moyano de Navascués, investment manager, Amadeus Ventures

The vertical take-off and landing jet developer, an Unternehmertum spinout, is joining forces with the Nasdaq-listed Qell Acquisition Corp.

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.

Post-acquisition, the DMGT-backed online vehicle marketplace's valuation will be nearly three times that of its last funding round five months ago.

Heidelberg Instruments Mikrotechnik has acquired the Fraunhofer spinout for an undisclosed sum.

The Tencent-backed vertical take-off and landing jet developer is joining forces with the Nasdaq-listed Qell Acquisition Corp.